Copy number variation analysis and targeted NGS in 77 families with suspected Lynch syndrome reveals novel potential causative genes

In many families with suspected Lynch syndrome (LS), no germline mutation in the causative mismatch repair (MMR) genes is detected during routine diagnostics. To identify novel causative genes for LS, the present study investigated 77 unrelated, mutation‐negative patients with clinically suspected LS and a loss of MSH2 in tumor tissue. An analysis for genomic copy number variants (CNV) was performed, with subsequent next generation sequencing (NGS) of selected candidate genes in a subgroup of the cohort. Genomic DNA was genotyped using Illumina's HumanOmniExpress Bead Array. After quality control and filtering, 25 deletions and 16 duplications encompassing 73 genes were identified in 28 patients. No recurrent CNV was detected, and none of the CNVs affected the regulatory regions of MSH2. A total of 49 candidate genes from genomic regions implicated by the present CNV analysis and 30 known or assumed risk genes for colorectal cancer (CRC) were then sequenced in a subset of 38 patients using a customized NGS gene panel and Sanger sequencing. Single nucleotide variants were identified in 14 candidate genes from the CNV analysis. The most promising of these candidate genes were: (i) PRKCA, PRKDC, and MCM4, as a functional relation to MSH2 is predicted by network analysis, and (ii) CSMD1, as this is commonly mutated in CRC. Furthermore, six patients harbored POLE variants outside the exonuclease domain, suggesting that these might be implicated in hereditary CRC. Analyses in larger cohorts of suspected LS patients recruited via international collaborations are warranted to verify the present findings.

[1]  A. Valencia,et al.  Elucidating the molecular basis of MSH2‐deficient tumors by combined germline and somatic analysis , 2017, International journal of cancer.

[2]  P. Devilee,et al.  Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients , 2016, PloS one.

[3]  Hong Zhu,et al.  Proteomic Analysis of Differentially Expressed Proteins Involved in Peel Senescence in Harvested Mandarin Fruit , 2016, Front. Plant Sci..

[4]  P. Devilee,et al.  Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers , 2015, European Journal of Human Genetics.

[5]  Yongwook Choi,et al.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels , 2015, Bioinform..

[6]  M. Nöthen,et al.  Genome‐wide CNV analysis in 221 unrelated patients and targeted high‐throughput sequencing reveal novel causative candidate genes for colorectal adenomatous polyposis , 2015, International journal of cancer.

[7]  Christopher D. Heinen,et al.  Milestones of Lynch syndrome: 1895–2015 , 2015, Nature Reviews Cancer.

[8]  H. Morreau,et al.  Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer , 2014, European Journal of Human Genetics.

[9]  W. Frankel,et al.  Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. , 2014, Gastroenterology.

[10]  J. Peña-Diaz,et al.  The dual nature of mismatch repair as antimutator and mutator: for better or for worse , 2014, Front. Genet..

[11]  M. Loeffler,et al.  Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: A comprehensive analysis of 3,671 families , 2014, International journal of cancer.

[12]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[13]  A. Chapelle,et al.  Biallelic MUTYH mutations can mimic Lynch syndrome , 2014, European Journal of Human Genetics.

[14]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[15]  Michael Krawczak,et al.  Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3. , 2014, Carcinogenesis.

[16]  Chen,et al.  Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12 p 12 . 3 , 2014 .

[17]  C. Boland,et al.  Inversion of exons 1–7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population , 2013, Familial Cancer.

[18]  R. Scott,et al.  Copy Number Variation in Hereditary Non-Polyposis Colorectal Cancer , 2013, Genes.

[19]  D. Goldstein,et al.  Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.

[20]  D. Rujescu,et al.  Copy Number Variants in German Patients with Schizophrenia , 2013, PloS one.

[21]  R. Scott,et al.  Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients , 2013, BMC Medical Genomics.

[22]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[23]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[24]  M. Humphries,et al.  Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment , 2012, Proteomics.

[25]  P. Pearson,et al.  Germline copy number variations and cancer predisposition. , 2012, Future oncology.

[26]  N. Rajewsky,et al.  The SNF2‐like helicase HELLS mediates E2F3‐dependent transcription and cellular transformation , 2012, The EMBO journal.

[27]  M. Mahajan,et al.  A multiprotein complex necessary for both transcription and DNA replication at the β‐globin locus , 2010, The EMBO journal.

[28]  Insuk Lee,et al.  Characterising and Predicting Haploinsufficiency in the Human Genome , 2010, PLoS genetics.

[29]  W. Bodmer,et al.  MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions , 2010, Familial Cancer.

[30]  Dagmar Wieczorek,et al.  A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients , 2009, European Journal of Human Genetics.

[31]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[32]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[33]  Anthony R. Dallosso,et al.  Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. , 2008, Cancer research.

[34]  C. Yau,et al.  QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data , 2007, Nucleic acids research.

[35]  G. Parmigiani,et al.  Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapy , 2009, Radiation oncology.

[36]  J. Jiricny.  The multifaceted mismatch-repair system , 2006, Nature Reviews Molecular Cell Biology.

[37]  M. Kloor,et al.  Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer , 2005, International journal of cancer.

[38]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[39]  S. Scholnick,et al.  The role of CSMD1 in head and neck carcinogenesis , 2003, Genes, chromosomes & cancer.

[40]  A. Read,et al.  The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis , 2003, Genes, chromosomes & cancer.

[41]  A. Wagner,et al.  A 10‐Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North‐American kindred , 2002, Genes, chromosomes & cancer.

[42]  D. Grönemeyer,et al.  Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. , 2002, American heart journal.

[43]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[44]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[45]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.